Skip to main content

Table 1 Relationship between the CMTM6 and PD-L1 expression and clinical parameter

From: Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer

Variables CMTM6 expression P value PD-L1 expression P value
High (n = 145) Low (n = 40)   High (n = 140) Low (n = 45)  
Age    0.750    0.637
 < 60 72 21   69 24  
 ≥ 60 73 19   71 21  
Sex
 Male 102 24 0.214 93 33 0.387
 Female 43 16   47 12  
Size
 < 5 (cm) 51 10 0.226 45 16 0.672
 ≥ 5 (cm) 94 30   95 29  
Differentiation       
 Well 12 3 0.748 10 5 0.468
 Moderate 25 9   28 6  
 Poor 108 28   102 34  
Tumor location
 Upper 18 6 0.670 15 9 0.251
 Middle 19 7   21 5  
 Lower 108 27   104 31  
Borrmann type       
 III 110 33  < 0.001 111 32  < 0.001
 IV 35 7   30 12  
Invasive depth
 T1 1 1 0.359 2 0 0.645
 T2 24 9   25 8  
 T3 17 7   16 8  
 T4 103 23   96 30  
lymph node metastasis
 N0 27 16 0.005 25 18 0.002
 N1-N3 118 24   115 27  
Peritoneal recurrence (M)
 M0 119 38 0.043 113 42 0.007
 M1 26 2   27 1  
Stage (TNM)
 I 10 8 0.035 9 9 0.038
 II 20 4   19 5  
 III 105 27   102 29  
 IV 10 1   10 1  
PD-L1 expression
 Low 27 18  < 0.001    
 High 118 22     
  1. CMTM6 CKLF Like MARVEL Transmembrane Domain Containing 6, PD-L1 Programmed death ligand-1